Human Metabolome Technologies, Inc.JP:6090
Market cap
¥3.9B
P/E ratio
14.3x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Depreciation & amortization | 71 | 61 | 53 | 61 | 81 | 48 | 56 | 65 | 80 | 86 | 104 |
| Cash from operations | 66 | -58 | 45 | -178 | -265 | 184 | -34 | 324 | 285 | 237 | 374 |
| Capital expenditures | -103 | -18 | -32 | -85 | -142 | -35 | -27 | -142 | -99 | -32 | -149 |
| Cash from investing | -98 | -124 | -34 | -87 | -55 | -35 | -26 | -152 | -117 | -32 | -197 |
| Payments for dividends | - | - | - | - | - | - | - | - | - | -59 | -88 |
| Repurchases of common stock | - | - | - | -0 | - | -0 | - | - | -0 | - | -166 |
| Repayments of term debt | -47 | -17 | -14 | - | - | - | - | - | - | - | - |
| Cash from financing | -17 | -28 | 355 | 5 | 3 | 22 | 86 | 80 | -14 | -73 | -369 |